HIV testing policies and practices vary widely across Europe. It is clear that there are individuals who might present late for HIV diagnosis and care within all risk groups, and potentially in any healthcare setting. This article explores the need to ensure earlier identification and treatment of late-presenting patients by reviewing strategies that might be considered. Such strategies could include routine provider-initiated HIV testing of at-risk groups in settings such as sexually transmitted infection clinics, drug dependency programmes or antenatal care. Healthcare providers might also consider routine HIV testing in all healthcare facilities, in settings including emergency and primary care, where local HIV prevalence is above a threshold that should be further evaluated. They should also take advantage of rapid testing technologies and be aware of barriers to HIV testing among specific groups to provide opportunities for testing that are relevant to local communities.
As described elsewhere in this supplement by Moreno et al. [1] , late presentation is associated with increased risk of morbidity and mortality, requires greater resource use to manage and contributes to the spread of the HIV epidemic. For the European Union as a whole, one analysis estimated that 30% of individuals infected with HIV are undiagnosed [2] . Earlier testing is therefore essential to reduce the prevalence of late presentation. Here, we review testing strategies that are currently used in Europe, and consider possible improvements or expansions. Specific recommendations regarding which strategies should be implemented can be found in the concluding article of this supplement by Antinori et al. [3] .
What testing strategies are currently in place?
Across Europe, HIV testing strategies vary. A 2007 survey on HIV testing policies and practices, conducted by Mounier-Jack et al. [4] , was sent to HIV experts in 33 European countries, of which 24 countries (73%) responded. The survey found that HIV testing is accessed in a wide variety of healthcare settings, including hospitals, general and primary care practices, sexually transmitted infection (STI) clinics (where available) and, in many countries, antenatal clinics. Testing was free of charge in at least some settings in each country [4] .
In many countries, patient-initiated approaches have been and continue to be the primary model for providing HIV testing and counselling. However, health facilities represent a key point of contact for people with HIV who are unaware of their HIV status. In the survey by Mounier-Jack et al. [4] , several countries were found to have testing strategies that primarily operated through primary care practitioners (Denmark, Germany, the Netherlands, Norway, Spain and Switzerland), whereas in some other countries, primary care practitioners were not even marginally involved in HIV testing (Bulgaria, Greece, Italy, Portugal, the Russian Federation and Slovakia) [4] . World Health Organization (WHO) guidance on HIV testing was published in 2007 in response to a perceived need for 'basic operational guidance'. These guidelines recommend implementation of provider-initiated HIV testing and counselling in STI services, services for the most at-risk populations ( 
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antenatal, childbirth and post-partum health services, and tuberculosis (TB) services [5] . Indeed, in the survey by Mounier-Jack et al. [4] , routine HIV testing for STI patients and pregnant women was reported by a majority of countries (Table 1 ). The survey also investigated the provision of routine testing in facilities for other at-risk populations, including antenatal services, TB clinics and prison facilities. Only 10 countries reported policies of routine testing in all the facilities identified [4] . Moreover, several respondents noted that despite policy, coverage in many settings, in particular for TB patients and prisoners, is low and inconsistent [4] . A survey of HIV testing practices among 281 registrars in the Sheffield National Health Service Trust in the UK found that only one-half of respondents had performed an HIV test in the previous 6 months [6] . WHO guidance also recommends an 'opt-out' approach, including the provision of simplified pre-test information, to provider-initiated HIV testing and counselling in health facilities [5] . In this model, individuals attending a given healthcare setting are offered and recommended an HIV test as standard, but can decline. In the survey by Mounier-Jack et al. [4] , 14 countries stated that they have a policy of recommending provider-initiated opt-out testing (Table 1) ; however, the precise meaning of 'opt-out testing' appeared to vary between countries and a few respondents indicated that their guidelines were ambiguous.
In a randomized, controlled trial of four different methods of offering HIV testing in an antenatal setting, a direct verbal offer was found to be most effective [7] . This approach has been shown to result in consistently higher CD4 + T-cell counts at diagnosis in women detected through antenatal screening compared with other women and heterosexual men [8] . Studies carried out in North America also indicate that direct offers of HIV testing improve uptake rates in other settings, including emergency care [9, 10] .
The most recent national guidelines for HIV testing in Europe are published in the UK [11] . These guidelines recommend HIV testing in settings such as sexual health clinics, antenatal services, pregnancy services and drug dependency programmes, as well as routine testing in patients in whom HIV enters the differential diagnosis, patients with an STI, sexual partners of HIV-positive individuals, MSM, IDUs and individuals from countries with HIV prevalence >1% and their sexual contacts. Moreover, they state that HIV testing 
should be considered in general practice and all general medical admissions, if local HIV prevalence exceeds 2 in 1,000 [11] .
Barriers to earlier testing: why do patients present late?
Late testing increases with age and is more prevalent in the heterosexual and migrant populations
Historically, 'late presentation' has not been well defined, and this has made comparisons between countries and across time -indeed, between any two given studieschallenging [12] [13] [14] [15] . In studies that defined late presentation as presentation with either clinical AIDS or with a CD4 + T-cell count <200 cells/µl, the risk of late presentation for HIV infection has been found to increase with age, and to be increased in heterosexual and migrant populations; in most cases, migrant men have been found to be particularly at risk [8, [16] [17] [18] . These associations have been documented in a recent French study [8] , where the risk of late presentation was increased 3.5-fold in those aged >60 years (versus those aged <30 years), 1.6-fold in heterosexuals (versus MSM) and 1.9-fold in migrant men (versus non-migrant women). Overall, 52% of HIV-infected patients >60 years of age were late presenters. Recently, tremendous efforts have been made to establish a common definition for late presentation. Presentation with a CD4 + T-cell count <200 cells/ µl has been defined as presentation with 'advanced HIV disease', whereas presentation with a CD4 + T-cell count below the level at which treatment should be initiated (currently <350 cells/µl), or with AIDS, has been defined as 'late presentation' [12] [13] [14] [15] .
Barriers to testing for HIV at the patient level
Most studies investigating barriers to HIV testing focus on the settings and patient groups associated with the most significant and obvious barriers. These are often settings on the margins of society and patients who face exclusion for one reason or another. A US-based cross-sectional interview study that evaluated the reasons for testing or not testing individuals at high risk for HIV infection in 1995-1996 and 1998-1999 found that those at highest risk were MSM, IDUs and heterosexual individuals recruited from gay bars, street outreach programmes and STI clinics [19] . In this survey, reasons offered for not being tested included denial of HIV risk factors and the fear of being diagnosed HIVpositive. Respondents who had not been tested for HIV were less likely to believe that medical care can maintain the health of those who are HIV-positive, and had less knowledge of HIV risk factors, than respondents who had been tested. These findings are supported by a review that evaluated psychosocial factors that influence individuals' uptake of HIV testing in high-income countries. The authors concluded that published literature illustrates that initial HIV testing appears to be more likely when individuals perceive that they have been at risk [20] . For example, older individuals or heterosexual individuals might not perceive themselves as being at risk of HIV infection. The authors also noted that 'fear of the consequences of testing positive -mainly worries related to discrimination and rejection -also hinders HIV testing'. In addition, those individuals who perceive benefits from testing appear to be more likely to test for HIV [20] .
A recent systematic literature review has summarized the barriers to HIV testing in Europe that have been identified at the patient level, the provider level and the policy level (Table 2 ) [21] . Although some caveats apply to this analysis (15 of 24 studies included were conducted in the UK, and only studies with an English-language publication were included) its findings support and extend those of the two studies discussed so far. For patients, the barriers to HIV testing were grouped into four categories, each of which was observed in both UK-based and non-UK-based studies [21] . First, and most significantly, patients in many populations, such as pregnant women, consider themselves to be at low risk for HIV infection. This is the most common reason why individuals do not receive an HIV test. Second, fear of the disease itself can be a significant deterrent. Third, fear of disclosure, and subsequent social or legal stigma, is common among migrant populations, and in some other groups. And fourth, not all populations have easy access to HIV testing services [21] .
Barriers for migrants
Migrants in Europe face additional obstacles to HIV testing. In Switzerland, migrants present with significantly lower mean ±sd CD4 + T-cell counts (326 [22] . A British study that examined the situation among immigrant African communities found that although general HIV awareness was high, perceptions of individual risk were poor [23] . Informants interviewed by the investigators reported that HIV remains stigmatized within African communities in the UK -'HIV is predominantly a sexually transmitted infection, and thus carries connotations about personal character' -and that this stigma remains a major barrier to accessing HIV testing and other HIV services. A recent Ugandan study found that individuals who assumed they were infected with HIV were less likely to refer other family members for testing than individuals who did not, and that members of a family in which one individual had tested positive were more reluctant to be tested than members of a family with no members with HIV infection [24] .
Other barriers reported include the perception that HIV is a deadly disease, the belief that the results of HIV tests are not confidential, and that a diagnosis of HIV infection would either reduce an individual's chance of success when applying for permanent residence or bring them to the attention of immigration services [23] . Furthermore, migrants' cultural norms often contribute to late presentation. In British African communities, individuals present to health services only when they have an immediate and specific requirement; the idea of testing when asymptomatic, even when the risk of infection is high, is rejected. Cultural norms also make it less likely that migrant African men present to health services in situations where opportunistic dialogue about HIV testing is possible, such as paediatric care [23] .
More generally, other difficulties faced by migrants tend to reduce HIV and health service use. For many sub-Saharan migrants, housing, childcare and employment are more urgent issues. Institutional barriers, such as limited availability of community clinics or a perceived failure of primary care practitioners to address HIV-related topics with their patients, can exacerbate these problems. Moreover, in this population, language barriers can distort health messages; that is, migrants might not understand that healthcare services are available, or that they are entitled to receive them [23] .
Barriers to HIV testing observed by physicians and missed HIV testing opportunities
Available evidence suggests that many opportunities to diagnose and counsel individuals at health facilities are being missed [25, 26] . In a study, conducted in the UK in 2008, of African patients newly diagnosed with HIV who were from a region known to have a high prevalence of HIV, more than three-quarters had seen their primary care practitioner in the year before diagnosis, yet the possibility of HIV testing had been raised in only 17% of cases [25] .
One US-based review of published literature found over 40 barriers to HIV testing identified by physicians [27] . Studies investigating HIV testing barriers identified in this review were divided into three categories: prenatal, emergency department and other medical settings. Eight barriers were identified in all three categories. The consent process and pre-test counselling requirements, for example, were reported to be particularly burdensome for physicians who are not in specialist settings, and do not have expert support regarding the diagnosis and management of HIV. Logistical barriers include competing priorities and language challenges, particularly when a physician might have to dedicate additional time to improving patient understanding of HIV. Physicians could face educational barriers themselves, might be unaware of which groups and behaviours indicate a high risk for HIV infection, and might make assumptions about which patients are at risk for HIV infection or which will be insulted by the offer of a test [27, 28] . In the systematic literature review described above, barriers identified to HIV testing in Europe at the provider level included lack of knowledge and training about HIV testing, and lack of self-confidence when proposing HIV testing [21] . GPs revealed that raising the issue of HIV testing was associated with a high level of anxiety, and that as a result they avoided rather than promoted discussion of HIV testing.
Overcoming barriers: encouraging earlier testing
Specific recommendations for HIV testing strategies are highlighted elsewhere in this supplement [3] . In this section, we discuss strategies that could be implemented to permit earlier testing.
Routine screening of at-risk groups in healthcare settings
In line with guidelines such as those discussed earlier [5, 11] , routine HIV testing could be offered in all healthcare settings where high-risk individuals are seen regularly, such as drug addiction treatment services and STI clinics. A Portuguese study reviewed the value of STI clinics in identifying patients with recently acquired HIV infections, and demonstrated the viability of testing at these 'sentinel' sites [29] . Individuals with conditions that share similar routes of transmission, such as STIs and viral hepatitis, and patients with TB, should also be routinely tested, along with MSM, IDUs and those who live in areas with a high incidence of HIV infection [30, 31] . A UK study has suggested that rates of diagnosis might be improved by educating individuals in high-risk groups (for example, MSM) to access healthcare when they experience symptoms of seroconversion [25] . Guidelines also indicate that routine HIV testing and counselling should be offered as early as possible during pregnancy to enable pregnant women to access interventions for reducing HIV transmission to their infants.
In addition, healthcare providers could recommend HIV testing and counselling as part of the standard of care to all individuals who present to health facilities with signs or symptoms that could indicate HIV infection. The most recent British HIV Association guidelines identify the key symptoms of acute HIV infection as fever, rash (maculopapular), myalgia, pharyngitis and headache/aseptic meningitis [11] . This would also include all patients showing signs of immune suppression, and those in whom HIV enters the differential diagnosis. The UK study mentioned above suggested that providers of non-HIV-related healthcare could benefit from training in HIV case recognition -an opportunity to diagnose infected individuals earlier during the symptomatic period [25] .
Note that standard HIV antibody testing (enzyme immunoassay or western blot) might not detect virus in patients with acute HIV infection: in patients at risk for recent infection, nucleic-acid-based testing should be considered. In healthcare settings where high-risk individuals are seen regularly, such as STI clinics, in order to detect individuals with acute HIV infection who are viraemic but antibody-negative, the addition of pooled nucleic acid amplification testing to an HIV testing algorithm should be considered, as it has been shown to significantly increase the identification of cases of infection [32] .
Routine screening of the general population
The survey of HIV testing policies and practices discussed earlier, which involved HIV experts from national public health institutes, ministries of health and major advocacy groups in 33 European countries, found that only one-half of the countries have national guidance on HIV testing [4] . The lack of policy and/or lack of unified policy, and the absence of rapid and easily accessible testing in many countries in Europe could thus be compounding the individual, cultural and societal barriers that currently contribute to the relatively high rates of late presentation across Europe; however, even in a perfect system, a proportion of patients will still present late for testing and treatment, especially if detection practices are riskfactor based.
Some authors advocate routine testing for those at low risk, on the grounds that current policy, which is focused on screening high-risk individuals, places those at low risk of HIV infection (such as heterosexuals with stable partners) at high risk of late detection if they become infected [16] . In addition, focusing testing on groups from marginalized populations (for example, recent migrants) or those engaging in socially taboo behaviours (for example, MSM) using risk-based strategies might exacerbate stigma in these populations. Finally, there is increasing evidence that effective prevention counselling, early detection and linkage to care can reduce the burden of HIV both for individuals and at the population level, providing further support for routine testing even of those at low risk [33, 34] .
In the US, the most recent CDC recommendations suggest that routine HIV testing should be offered in all healthcare settings for patients aged 13-64 years, unless local HIV prevalence is known to be <0.1% [35] . These recommendations were, in part, based on two cost-effectiveness studies showing that this approach is economically justifiable in the US setting. In one study, the cost-effectiveness of one-time HIV routine screening was estimated to be USD 60,700/quality-adjusted life year (QALY; 2009 EUR 46,067/QALY) when the prevalence of undiagnosed HIV was 0.1% and secondary infections were taken into account [36] . In the other study, the cost-effectiveness of routine HIV screening in healthcare settings was found to be USD 50,000/QALY (2009 EUR 34,378/QALY) after considering reductions in transmission when the prevalence of undiagnosed HIV was 0.05% [37] . Data supporting routine screening are relatively limited, and to date this approach is rarely used in European settings. Recently, a model-based analysis illustrated that universal, routine, voluntary HIV screening in France is clinically effective and cost-effective compared with the current risk-factor-based testing strategy [38] . This study is the first to evaluate the cost-effectiveness of universal routine, voluntary HIV screening in Europe. On the basis of these results, the French National Authority for Health recommended one-time routine, voluntary HIV screening in the French general population in October 2009 [39] . UK guidelines recommend that HIV testing should be considered in general practice and all general medical admissions if local HIV prevalence is >2 in 1,000 [11] .
Improving recognition by healthcare providers 'Normalization' of HIV testing is desirable, but requires all doctors to be competent and confident at HIV testing and diagnosis, and the process for treating HIV to be similar to that for other infectious diseases [31] . At present, primary care physicians often see HIVinfected individuals several times before an infection is confirmed. Lack of physician knowledge and training should be addressed through continued education of the medical community [27] .
The logistical complexities of pre-test consent and counselling could be reduced by streamlining the process. An 'opt-out' model with oral consent could be appropriate at some sites -particularly in genitourinary and prenatal clinics. Another option could be to 'normalize' HIV testing by removing a requirement for separate written consent and including it in general consent for medical care. In such cases, however, specific mention should be made of the inclusion of HIV testing in a standard panel of tests, to allow those with strong objections the opportunity to refuse; fast referral procedures for patients found to have HIV are also essential. Better links with community groups to incorporate counselling and supportive functions regarding testing and diagnosis might also help to address physicians' concerns when testing.
Reducing stigma associated with testing and societal acceptance of testing Patients should receive adequate information about HIV testing and prognosis. A refusal to test should be explored to correct any misperceptions about testing or the disease. It is especially important that the implications of a positive result are thoroughly explained, particularly in migrant populations. This will avoid linguistic confusions -such as the notion that a 'positive' result is good news -and allay concerns that a diagnosis of HIV will restrict migrants' access to services, or lead to their being sent back to their country of origin.
To break down specific cultural and social barriers, testing services need to be appropriate to the personal and cultural needs of individuals. Approaches to increase testing in migrant populations include more involvement from the African communities in the planning and implementation of health services, facilitating easier access to testing services (for example, testing via general practitioners rather than by referral to sexual health centres), and attention to the unique barriers that such populations face when accessing healthcare in a new country [23] . It is essential to reduce the stigma associated with testing HIV-positive, which is already a substantial barrier to taking an HIV test [4] , and could be unintentionally exacerbated by testing policies that focus on marginalized or socially taboo groups. A UK programme of anonymous testing of leftover blood samples from STI clinic attendees showed that homosexual men with undiagnosed HIV are more likely to refuse an HIV test than heterosexuals with undiagnosed HIV, a finding that needs more research [40, 41] .
Partner notification by healthcare department personnel has been proposed as an effective method to reduce transmission and prevent new infections. This could have greater potential if combined with social networking communication strategy to identify individuals at risk of infection and prompt people not previously considered to be at high risk to be tested for HIV [30] . In the US, anonymous partner notification via text message or e-mail from an STI clinic has been trialled with some success [42] .
Rapid testing in non-medical settings and/or as part of community outreach exercises is one possible way of offsetting cultural barriers to HIV testing. A trial programme in the UK involved six community-based sites where rapid HIV antibody testing was provided free of charge on a 'first come, first served' basis [43] . When asked why they chose to be tested at these sites, the most common responses were that it was more convenient than at a sexual health clinic (33%) and that having the results available at the same visit was attractive (52%). Nearly half of the heterosexual patients tested had never previously received an HIV test, indicating some success at reaching groups at risk of late presentation [43] . Similar positive results have been reported with the use of rapid testing at a walk-in MSM community centre in Barcelona; this model is to be trialled in other urban areas in Spain (F Pujol, Projecte dels NOMSHispanosida, personal communication).
Linking testing to medical care
Earlier testing and diagnosis are essential to reduce the frequency of late presentation of HIV. However, from a public health point of view, maximizing the proportion of patients with HIV who are aware of their diagnosis is unambiguously good only if these patients feel able to use this knowledge to seek appropriate care: at present this is not necessarily the case. Recent surveys from three UK clinics found that between 7.5% and 35.0% of patients who received a positive HIV test result did not attend for further appointments; the loss to follow-up rate might be even higher for patients tested in primary care settings [44, 45] . It is therefore essential that patients who test positive for HIV infection are correctly and rapidly referred to clinical follow-up, counselling and HIV support services.
Conclusions
At present, substantial barriers to HIV testing exist across Europe at the individual, societal, medical and public policy levels. Specific recommendations from this European Working Group for improving HIV testing can be found elsewhere in this supplement [3] ; however, country-specific HIV testing guidelines should be updated, audited and disseminated on a regular basis. These guidelines should consider the value of routine screening in different healthcare settings and, with the availability of rapid tests, screening in community settings that might be particularly relevant to groups at high risk of late presentation.
